Local first hypertension +hyperlipidemia combination ‘Robelito’ available in the market soon
(Newspaper Chungnyun Doctor)
The fixed dose combination (FDC) of hypertension drug Irbesratan and hyperlipidemia drug Atorvastatin is going to launch in Korea.
Hanmi and Sanofi revealed that the marketing autho...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
